PROPANC BIOPHARMA, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PROPANC BIOPHARMA, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $3.31M.
- PROPANC BIOPHARMA, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $2.26K.
- PROPANC BIOPHARMA, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $48.47K.
- PROPANC BIOPHARMA, INC. stock issued during period, value, new issues for fiscal 2023 was $48.47K, a 51.18% decline from fiscal 2022.
- PROPANC BIOPHARMA, INC. stock issued during period, value, new issues for fiscal 2022 was $99.28K.
- PROPANC BIOPHARMA, INC. stock issued during period, value, new issues for fiscal 2020 was $424.99K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-09-30 | $3.31M S-1 · filed 2026-07-17 | |
| 2024-06-30 | $23.06K S-1 · filed 2026-07-17 | |
| 2024-03-31 | $2.26K 10-Q · filed 2025-05-15 | |
| 2023-06-30 | $48.47K 10-K · filed 2024-09-30 | |
| 2022-09-30 | $48.47K 10-Q · filed 2024-05-15 | |
| 2022-06-30 | $99.28K 10-K · filed 2023-09-28 | |
| 2020-06-30 | $424.99K 10-K · filed 2021-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |